Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 81 | 2024 | 3047 | 6.810 |
Why?
|
Pulmonary Emphysema | 19 | 2024 | 672 | 3.530 |
Why?
|
Emphysema | 5 | 2024 | 247 | 1.800 |
Why?
|
Smoking | 26 | 2023 | 8987 | 1.470 |
Why?
|
Forced Expiratory Volume | 20 | 2023 | 1743 | 1.400 |
Why?
|
Genome-Wide Association Study | 41 | 2023 | 12261 | 1.340 |
Why?
|
Genetic Predisposition to Disease | 40 | 2023 | 17446 | 1.340 |
Why?
|
Spirometry | 13 | 2023 | 864 | 1.320 |
Why?
|
Idiopathic Pulmonary Fibrosis | 6 | 2023 | 451 | 1.260 |
Why?
|
Lung | 29 | 2023 | 9856 | 1.200 |
Why?
|
Genetic Loci | 8 | 2019 | 2575 | 1.170 |
Why?
|
Gene Expression | 8 | 2021 | 7799 | 0.850 |
Why?
|
Polymorphism, Single Nucleotide | 28 | 2023 | 15519 | 0.800 |
Why?
|
alpha 1-Antitrypsin | 3 | 2022 | 164 | 0.750 |
Why?
|
Cluster Analysis | 7 | 2022 | 2715 | 0.700 |
Why?
|
Sequence Analysis, RNA | 8 | 2022 | 2012 | 0.700 |
Why?
|
Respiratory Function Tests | 11 | 2022 | 1616 | 0.680 |
Why?
|
Quantitative Trait Loci | 9 | 2023 | 2019 | 0.670 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 75 | 0.660 |
Why?
|
Gene Regulatory Networks | 6 | 2023 | 1708 | 0.660 |
Why?
|
Molecular Epidemiology | 2 | 2019 | 468 | 0.640 |
Why?
|
RNA, Untranslated | 2 | 2020 | 453 | 0.610 |
Why?
|
Exons | 4 | 2023 | 2437 | 0.590 |
Why?
|
Computational Biology | 5 | 2021 | 3521 | 0.580 |
Why?
|
Gene Expression Profiling | 10 | 2024 | 9438 | 0.570 |
Why?
|
GTPase-Activating Proteins | 2 | 2019 | 498 | 0.550 |
Why?
|
Phenotype | 20 | 2022 | 16365 | 0.470 |
Why?
|
Adaptive Immunity | 1 | 2018 | 713 | 0.440 |
Why?
|
Health Care Coalitions | 1 | 2012 | 35 | 0.420 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2015 | 374 | 0.400 |
Why?
|
Disease Progression | 12 | 2023 | 13284 | 0.390 |
Why?
|
Fibroblasts | 2 | 2019 | 4161 | 0.380 |
Why?
|
Classification | 1 | 2011 | 129 | 0.370 |
Why?
|
Models, Statistical | 4 | 2021 | 5102 | 0.370 |
Why?
|
Respiratory System Agents | 1 | 2010 | 29 | 0.370 |
Why?
|
Protein Isoforms | 4 | 2022 | 1730 | 0.370 |
Why?
|
Community Networks | 1 | 2012 | 203 | 0.360 |
Why?
|
Leukocytes | 1 | 2018 | 2043 | 0.350 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2011 | 403 | 0.350 |
Why?
|
Nebulizers and Vaporizers | 1 | 2010 | 139 | 0.340 |
Why?
|
Health Services for the Aged | 1 | 2012 | 269 | 0.340 |
Why?
|
Middle Aged | 58 | 2023 | 213383 | 0.330 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2009 | 107 | 0.330 |
Why?
|
Humans | 112 | 2024 | 744343 | 0.330 |
Why?
|
Indium Radioisotopes | 1 | 2008 | 118 | 0.330 |
Why?
|
Pentetic Acid | 1 | 2008 | 213 | 0.320 |
Why?
|
Aged | 49 | 2022 | 163280 | 0.320 |
Why?
|
Airway Resistance | 1 | 2009 | 404 | 0.320 |
Why?
|
Epoxide Hydrolases | 1 | 2008 | 122 | 0.310 |
Why?
|
Octreotide | 1 | 2008 | 145 | 0.310 |
Why?
|
Proteomics | 8 | 2024 | 3638 | 0.310 |
Why?
|
Gene Expression Regulation | 8 | 2023 | 12072 | 0.310 |
Why?
|
Immunity, Innate | 1 | 2018 | 2958 | 0.270 |
Why?
|
Tomography, X-Ray Computed | 17 | 2023 | 20129 | 0.260 |
Why?
|
Male | 61 | 2022 | 350118 | 0.260 |
Why?
|
Female | 62 | 2023 | 380194 | 0.240 |
Why?
|
Aged, 80 and over | 22 | 2022 | 57776 | 0.240 |
Why?
|
Polyadenylation | 2 | 2021 | 117 | 0.240 |
Why?
|
Bronchitis, Chronic | 1 | 2023 | 62 | 0.230 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1107 | 0.230 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2008 | 1121 | 0.220 |
Why?
|
Severity of Illness Index | 9 | 2022 | 15540 | 0.220 |
Why?
|
Longitudinal Studies | 14 | 2023 | 13989 | 0.210 |
Why?
|
Databases, Genetic | 1 | 2009 | 1783 | 0.210 |
Why?
|
Tomography, Spiral Computed | 2 | 2014 | 280 | 0.210 |
Why?
|
Neuroendocrine Tumors | 1 | 2008 | 594 | 0.210 |
Why?
|
RNA Splice Sites | 1 | 2023 | 209 | 0.210 |
Why?
|
DNA | 2 | 2020 | 7301 | 0.210 |
Why?
|
Drug Costs | 1 | 2010 | 1105 | 0.210 |
Why?
|
Smoking Cessation | 2 | 2024 | 2071 | 0.200 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2019 | 644 | 0.190 |
Why?
|
Cachexia | 2 | 2020 | 204 | 0.190 |
Why?
|
Genotype | 6 | 2023 | 12951 | 0.190 |
Why?
|
Alternative Splicing | 3 | 2023 | 1117 | 0.190 |
Why?
|
Desmoplakins | 1 | 2020 | 62 | 0.190 |
Why?
|
Vital Capacity | 5 | 2023 | 925 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4479 | 0.180 |
Why?
|
Asthma | 5 | 2021 | 6011 | 0.180 |
Why?
|
Chromosomes, Human, Pair 15 | 3 | 2015 | 373 | 0.170 |
Why?
|
Receptors, Cell Surface | 1 | 2008 | 2866 | 0.170 |
Why?
|
Pulmonary Eosinophilia | 1 | 2019 | 82 | 0.170 |
Why?
|
Respiration Disorders | 1 | 2022 | 371 | 0.170 |
Why?
|
RNA Splicing | 1 | 2023 | 907 | 0.160 |
Why?
|
Activin Receptors, Type I | 1 | 2019 | 142 | 0.160 |
Why?
|
Medication Adherence | 1 | 2010 | 2063 | 0.160 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2645 | 0.160 |
Why?
|
Heme | 1 | 2020 | 307 | 0.160 |
Why?
|
RNA, Messenger | 4 | 2023 | 13033 | 0.150 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 1537 | 0.150 |
Why?
|
F-Box Proteins | 1 | 2019 | 197 | 0.150 |
Why?
|
Genetic Pleiotropy | 1 | 2019 | 182 | 0.150 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15076 | 0.150 |
Why?
|
Leukocyte Count | 2 | 2018 | 1588 | 0.150 |
Why?
|
Health Expenditures | 1 | 2010 | 2348 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3597 | 0.150 |
Why?
|
Genetic Variation | 5 | 2020 | 6544 | 0.140 |
Why?
|
Linkage Disequilibrium | 2 | 2014 | 1997 | 0.140 |
Why?
|
Cohort Studies | 15 | 2022 | 40561 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 570 | 0.140 |
Why?
|
Macrophages, Alveolar | 1 | 2019 | 407 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 794 | 0.140 |
Why?
|
Iron Regulatory Protein 2 | 2 | 2015 | 41 | 0.140 |
Why?
|
Case-Control Studies | 7 | 2022 | 21746 | 0.140 |
Why?
|
Epigenomics | 2 | 2019 | 903 | 0.140 |
Why?
|
rac GTP-Binding Proteins | 1 | 2017 | 164 | 0.140 |
Why?
|
Chromosome Mapping | 2 | 2014 | 4740 | 0.140 |
Why?
|
Respiratory Mucosa | 1 | 2019 | 427 | 0.130 |
Why?
|
Metabolomics | 2 | 2021 | 1484 | 0.130 |
Why?
|
Airway Remodeling | 1 | 2017 | 132 | 0.130 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2018 | 638 | 0.130 |
Why?
|
Serpin E2 | 2 | 2020 | 48 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 924 | 0.130 |
Why?
|
Heterozygote | 1 | 2022 | 2804 | 0.130 |
Why?
|
Oxygen | 2 | 2018 | 4189 | 0.130 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 24 | 0.130 |
Why?
|
Bronchi | 1 | 2018 | 840 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1518 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2203 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.120 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.120 |
Why?
|
Airway Obstruction | 1 | 2018 | 664 | 0.110 |
Why?
|
Eosinophils | 1 | 2018 | 955 | 0.110 |
Why?
|
Chemokines | 1 | 2017 | 970 | 0.110 |
Why?
|
Genomics | 3 | 2018 | 5720 | 0.110 |
Why?
|
Models, Genetic | 3 | 2020 | 3494 | 0.110 |
Why?
|
Risk Factors | 15 | 2022 | 72290 | 0.110 |
Why?
|
Receptors, Nicotinic | 2 | 2015 | 497 | 0.110 |
Why?
|
Pulmonary Fibrosis | 1 | 2017 | 530 | 0.110 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.110 |
Why?
|
Hepatitis C | 1 | 2023 | 1591 | 0.110 |
Why?
|
New South Wales | 1 | 2012 | 66 | 0.110 |
Why?
|
Propensity Score | 1 | 2019 | 1781 | 0.110 |
Why?
|
Cytokines | 2 | 2017 | 7322 | 0.110 |
Why?
|
Risk Assessment | 5 | 2022 | 23338 | 0.100 |
Why?
|
Cadherins | 1 | 2017 | 907 | 0.100 |
Why?
|
DNA Methylation | 2 | 2023 | 4286 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1799 | 0.100 |
Why?
|
Blood Proteins | 1 | 2016 | 1124 | 0.100 |
Why?
|
beta Catenin | 1 | 2016 | 1059 | 0.100 |
Why?
|
Pneumothorax | 1 | 2014 | 379 | 0.100 |
Why?
|
Genetic Markers | 2 | 2022 | 2634 | 0.090 |
Why?
|
PubMed | 1 | 2011 | 123 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3339 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 367 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2020 | 3690 | 0.090 |
Why?
|
Norway | 1 | 2010 | 448 | 0.090 |
Why?
|
Prospective Studies | 6 | 2023 | 53288 | 0.090 |
Why?
|
Genome, Human | 3 | 2015 | 4420 | 0.090 |
Why?
|
Protease Nexins | 1 | 2008 | 40 | 0.090 |
Why?
|
Body Mass Index | 2 | 2017 | 12720 | 0.090 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 1 | 2008 | 42 | 0.080 |
Why?
|
Genetic Linkage | 1 | 2014 | 2421 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39050 | 0.080 |
Why?
|
Software | 2 | 2020 | 4443 | 0.080 |
Why?
|
Online Systems | 1 | 2009 | 184 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 990 | 0.080 |
Why?
|
Biostatistics | 1 | 2010 | 162 | 0.080 |
Why?
|
Health Services | 1 | 2013 | 758 | 0.080 |
Why?
|
Genome | 1 | 2016 | 1808 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1341 | 0.080 |
Why?
|
Gene Frequency | 2 | 2016 | 3588 | 0.080 |
Why?
|
Glutathione Transferase | 1 | 2009 | 595 | 0.080 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2010 | 336 | 0.080 |
Why?
|
Sepsis | 1 | 2021 | 2593 | 0.070 |
Why?
|
Prognosis | 5 | 2023 | 29063 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2703 | 0.070 |
Why?
|
Hypercapnia | 1 | 2008 | 260 | 0.070 |
Why?
|
Adult | 13 | 2022 | 214055 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2009 | 597 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7722 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5952 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1790 | 0.070 |
Why?
|
United States | 5 | 2019 | 69872 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2008 | 981 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2017 | 19905 | 0.070 |
Why?
|
Dyspnea | 1 | 2013 | 1303 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 8949 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13408 | 0.070 |
Why?
|
ras Proteins | 1 | 2011 | 1060 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3507 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2012 | 2539 | 0.060 |
Why?
|
Genetics, Population | 1 | 2009 | 934 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2011 | 1005 | 0.060 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1344 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2018 | 11483 | 0.060 |
Why?
|
Qualitative Research | 1 | 2012 | 2682 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4462 | 0.050 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2023 | 188 | 0.050 |
Why?
|
Alleles | 3 | 2020 | 6933 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2052 | 0.050 |
Why?
|
Mucin-5B | 1 | 2023 | 141 | 0.050 |
Why?
|
Bronchodilator Agents | 2 | 2016 | 502 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2014 | 1736 | 0.050 |
Why?
|
Risk | 1 | 2014 | 9687 | 0.050 |
Why?
|
Multifactorial Inheritance | 2 | 2022 | 1194 | 0.050 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2021 | 49 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Databases, Factual | 2 | 2021 | 7729 | 0.050 |
Why?
|
Penetrance | 1 | 2023 | 381 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8664 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18029 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2021 | 127 | 0.050 |
Why?
|
Odds Ratio | 3 | 2022 | 9849 | 0.050 |
Why?
|
Genes, Switch | 1 | 2020 | 47 | 0.050 |
Why?
|
Lung Volume Measurements | 1 | 2021 | 378 | 0.050 |
Why?
|
Arylsulfotransferase | 1 | 2019 | 28 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 513 | 0.040 |
Why?
|
Stochastic Processes | 1 | 2020 | 344 | 0.040 |
Why?
|
CpG Islands | 1 | 2023 | 1172 | 0.040 |
Why?
|
Nicotine | 1 | 2024 | 681 | 0.040 |
Why?
|
Cause of Death | 2 | 2020 | 3584 | 0.040 |
Why?
|
Quality of Life | 3 | 2016 | 12804 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14722 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 706 | 0.040 |
Why?
|
Comorbidity | 3 | 2018 | 10388 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2011 | 4554 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13102 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1041 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15165 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 743 | 0.040 |
Why?
|
Mutation | 3 | 2023 | 29786 | 0.040 |
Why?
|
Mice | 6 | 2023 | 81183 | 0.040 |
Why?
|
Nedocromil | 1 | 2016 | 46 | 0.040 |
Why?
|
HIV Infections | 1 | 2023 | 16718 | 0.030 |
Why?
|
Time Factors | 1 | 2018 | 40075 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2023 | 1094 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 7785 | 0.030 |
Why?
|
Counseling | 1 | 2024 | 1523 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5751 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 977 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 671 | 0.030 |
Why?
|
Acetylation | 1 | 2018 | 1085 | 0.030 |
Why?
|
Hepacivirus | 1 | 2023 | 1379 | 0.030 |
Why?
|
Budesonide | 1 | 2016 | 154 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1211 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 557 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 2014 | 143 | 0.030 |
Why?
|
RNA, Viral | 1 | 2023 | 2902 | 0.030 |
Why?
|
Colorectal Neoplasms | 2 | 2011 | 6773 | 0.030 |
Why?
|
ABO Blood-Group System | 1 | 2016 | 367 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 635 | 0.030 |
Why?
|
Serpins | 1 | 2015 | 247 | 0.030 |
Why?
|
Lysine | 1 | 2018 | 1007 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2014 | 77449 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9274 | 0.030 |
Why?
|
Epithelium | 1 | 2018 | 1679 | 0.030 |
Why?
|
Adiponectin | 1 | 2019 | 1100 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1105 | 0.030 |
Why?
|
Drosophila | 1 | 2020 | 1491 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2014 | 223 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 895 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 3002 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7913 | 0.030 |
Why?
|
Incidence | 1 | 2010 | 20947 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2014 | 284 | 0.030 |
Why?
|
Netherlands | 1 | 2016 | 2170 | 0.030 |
Why?
|
Poland | 1 | 2012 | 184 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1656 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10638 | 0.030 |
Why?
|
Animals | 6 | 2023 | 168757 | 0.030 |
Why?
|
Sex Factors | 2 | 2016 | 10397 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18370 | 0.020 |
Why?
|
Oximetry | 1 | 2014 | 471 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Teratoma | 1 | 2014 | 395 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1903 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1838 | 0.020 |
Why?
|
Mesoderm | 1 | 2014 | 686 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1463 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2432 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21827 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2018 | 19229 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1654 | 0.020 |
Why?
|
Fibronectins | 1 | 2014 | 726 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 41006 | 0.020 |
Why?
|
Rest | 1 | 2014 | 901 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2014 | 770 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1878 | 0.020 |
Why?
|
Probability | 1 | 2014 | 2505 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1827 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10252 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2309 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3086 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2016 | 14557 | 0.020 |
Why?
|
Histones | 1 | 2018 | 2599 | 0.020 |
Why?
|
Algorithms | 2 | 2019 | 13881 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13695 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15997 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5655 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7474 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9959 | 0.020 |
Why?
|
Forecasting | 1 | 2014 | 2951 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6538 | 0.020 |
Why?
|
Collagen | 1 | 2014 | 2689 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.020 |
Why?
|
Signal Transduction | 2 | 2019 | 23403 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3920 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2618 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3768 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5987 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9146 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2421 | 0.020 |
Why?
|
Child | 3 | 2016 | 77709 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10180 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12354 | 0.010 |
Why?
|
Testicular Neoplasms | 1 | 2010 | 804 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6196 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1692 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16689 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2015 | 5021 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12208 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5217 | 0.010 |
Why?
|
Neoplasms | 1 | 2010 | 21683 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 56430 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2011 | 6895 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2019 | 20822 | 0.010 |
Why?
|
MicroRNAs | 1 | 2014 | 3752 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 2010 | 2282 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 35421 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 25043 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 85781 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11124 | 0.000 |
Why?
|